Colorectal Cancer Surgery During the COVID-19 Pandemic: A Single Center Experience

In Vivo. 2021 Mar-Apr;35(2):1299-1305. doi: 10.21873/invivo.12382.

Abstract

Background/aim: A notable re-allocation of healthcare resources and specific clinical and organizational measures have been required to prevent COVID-19 infection among hospitalized patients and healthcare workers.

Patients and methods: From March 9th to May 9th 2020 we performed colorectal cancer elective surgery on 25 patients: a pre-hospital screening was carried out in order to avoid hospitalization of patients suspected of COVID-19 infection.

Results: All patients (median age=76 years; range=37-88 years) were considered suitable for admission after telephone triage; the median interval between primary diagnosis and hospital admission was 23.1 days (range=1-55 days). The median hospitalization was 7.8 days (range=4-18 days). One COVID-19-associated death was reported.

Conclusion: Our experience demonstrates that safe colorectal cancer elective surgery can be performed during the pandemic COVID-19. Further consensus and guidelines to prevent diffusion of pandemic diseases among hospitalized patients and healthcare workers still need to be implemented.

Keywords: COVID 19; Colorectal cancer; colorectal surgery; healthcare; infections; prevention.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • Colorectal Neoplasms / surgery*
  • Elective Surgical Procedures / methods*
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Male
  • Medical Oncology / methods
  • Middle Aged
  • Pandemics
  • SARS-CoV-2 / isolation & purification*
  • SARS-CoV-2 / physiology